When was POLYPEPTIDE LABORATORIES PRIVATE LIMITED incorporated?

POLYPEPTIDE LABORATORIES PRIVATE LIMITED was incorporated on Feb 06, 2001. It is registered with the Registrar of Companies, Mumbai, and its current company status is Active.

What is the Corporate Identification Number (CIN) of POLYPEPTIDE LABORATORIES PRIVATE LIMITED?

POLYPEPTIDE LABORATORIES PRIVATE LIMITED's Corporate Identification Number (CIN) is U51397MH2001PTC130734.

What is the registered address of POLYPEPTIDE LABORATORIES PRIVATE LIMITED?

The registered address of POLYPEPTIDE LABORATORIES PRIVATE LIMITED is K-28, Additional MIDC Area, Anand Nagar, Ambernath (East), Thane, Ambernath, Maharashtra, India, 421506.

What is the latest employee count at POLYPEPTIDE LABORATORIES PRIVATE LIMITED?

As of Mar 31, 2024, the latest employee count at POLYPEPTIDE LABORATORIES PRIVATE LIMITED is 98, reflecting a 35% year-over-year decline in headcount.

Who are the authorized signatories of POLYPEPTIDE LABORATORIES PRIVATE LIMITED?

As of Jul 2026, the authorized signatories of POLYPEPTIDE LABORATORIES PRIVATE LIMITED include Ashok Dattatraya Alate, Navleen kaur Surinder Anand and Jens Fricke.

POLYPEPTIDE LABORATORIES PRIVATE LIMITED - 2026 Company Profile & Financials

Name: POLYPEPTIDE LABORATORIES PRIVATE LIMITED
Brand: POLYPEPTIDE LABORATORIES PRIVATE LIMITED
Price: 3.99 USD

POLYPEPTIDE LABORATORIES PRIVATE LIMITED is a Private Limited Company and was incorporated on Feb 06, 2001 in India. It is registered at Registrar of Companies, ROC Mumbai. Its registered address is K-28, Additional MIDC Area, Anand Nagar, Ambernath (East), Thane, Ambernath, Maharashtra, India, 421506. Its corporate identification number is (CIN) U51397MH2001PTC130734 and its current status is Active. Its industry classification as per MCA is wholesale Of Pharmaceutical And Medical Goods. It had a team size of 98 employees as on Mar 31, 2024.

POLYPEPTIDE LABORATORIES PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). POLYPEPTIDE LABORATORIES PRIVATE LIMITED's authorised share capital is ₹73.7Cr and its paid up capital is ₹60.4Cr. The current board of directors of POLYPEPTIDE LABORATORIES PRIVATE LIMITED comprises Ashok Dattatraya Alate, Jens Fricke and 1 more.

POLYPEPTIDE LABORATORIES PRIVATE LIMITED generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2025.

Key Metrics

CIN

U51397MH2001PTC130734

Location

India

Current Status

Active

Entity Type

Private Limited Company

Date Of Incorporation

Feb 06, 2001

Company Age

25 Years 5 Months

Registrar of Companies

ROC - Mumbai

Last AGM Date

Sep 30, 2025

Latest Revenue

₹50 - ₹100 Cr as on Mar 31, 2025

Latest Employee Count

98 as on Mar 31, 2024

Authorized Capital

₹73.7Cr

Paid Up Capital

₹60.4Cr

Email: *****@polypeptide.com
Registered Address: K-28, Additional MIDC Area, Anand Nagar, Ambernath (East), Thane, Ambernath, Maharashtra, India, 421506

There is one brand associated with POLYPEPTIDE LABORATORIES PRIVATE LIMITED which include PolyPeptide .

Name	Short Description	Founded Year	Location	Current Stage
PolyPeptide	CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides	1952	Switzerland	Public

View more details on POLYPEPTIDE LABORATORIES PRIVATE LIMITED's profile

The majority of POLYPEPTIDE LABORATORIES PRIVATE LIMITED's turnover comes from Manufacturing.

Main Activity Group Code	Description of Main Activity	Business Activity Code	Description of Business Activity	Turnover Percentage
C	Manufacturing	21	Manufacture of basic pharmaceutical products and pharmaceutical preparations	xvr

Filing Summary

Here is a summary of filing activity and document availability across financial years:

File Type	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Financial Statements
Annual Returns

Latest Financials, Share Allotment and Annual Report

The latest filed financial documents, annual reports, and share allotment filings are shown below:

Changes to Capital Structure

Buy Now

Recent Filings

Below are the most recent filings submitted by the company:

Document Name	Category	Filing Date
Form PAS-6	Other eForm Documents	Apr 14, 2026
Form CSR-2	Annual Returns and Balance Sheet eForms	Dec 17, 2025
Form AOC-4(XBRL)	Annual Returns and Balance Sheet eForms	Dec 17, 2025
Form CSR-2	Annual Returns and Balance Sheet eForms	Dec 17, 2025
Form MSME	Other eForm Documents	Nov 06, 2025
Form MSME	Other eForm Documents	Nov 06, 2025
Optional attachment(s)- if any	Annual Returns and Balance Sheet eForms	Nov 05, 2025
List of share holders, debenture holders;	Annual Returns and Balance Sheet eForms	Nov 05, 2025
Form MGT-7	Annual Returns and Balance Sheet eForms	Nov 05, 2025
Photograph of the registered office of the Company showing external building and name prominently visible	Annual Returns and Balance Sheet eForms	Nov 05, 2025

To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available

POLYPEPTIDE LABORATORIES PRIVATE LIMITED generated between ₹50 Cr and ₹100 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of POLYPEPTIDE LABORATORIES PRIVATE LIMITED has a compounded annual growth rate (CAGR) of 34% in the last 1 year.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	8677	5939	7598	8809	6921
Total Sales	8393	7471	7357	2244	2556
Total Expenses	2455	7251	2186	5491	8390
Operating Expenses	3007	9878	6129	4108	6753
Employee Expenses	8905	9668	2582	1040	9171
Marketing Expenses	6662	8582	1262	3110	2292
Operating Income (EBIT)	8015	2197	1166	4457	5307
Interest Expenses	8491	8829	4768	7362	3936
Expenses from other activities	4171	7201	2941	2059	7017
Information Technology Expenses	5851	5127	1746	5539	3905
EBITDA	1460	2527	8193	2740	6003
Taxes	5447	9091	6409	1663	3559
Net Profit	5743	5834	2233	8944	6929
Balance Sheet
Assets	9347	1343	7843	2714	6035
Cash Equivalent	8497	3861	7037	6785	7555
Accounts Receivables	4059	8558	9175	7997	6157
Inventory	3021	4475	2210	4461	7133
Liabilities	6626	1771	9490	9422	9644
Total Debt	1695	5262	6483	8838	8686
Accounts Payable	2219	8036	6887	8778	7266
Equities	4055	6124	8763	6422	3105
Cashflow Statement
Cash from Operating activities	4002	6490	6293	7842	6285
Cash from Investing activities	5352	3736	7682	9542	7476
Net cash from Financing activities	7703	3544	8455	9552	4888

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Ratios

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Profitability Ratios
EBITDA Margin	2135	9429	5033	9274	2040
EBIT Margin	5542	2813	2872	3835	7788
Net Profit Margin	4251	2292	8954	1851	6932
Return on Assets (ROA)	3238	7847	8723	5366	5697
Return on Equity (ROE)	8431	5935	5136	9812	9726
Return on Capital Employed	8934	2234	5114	8533	2535
Return on Invested Capital	4793	1982	1951	1326	6030
Efficiency Ratios
Asset Turnover	6190	5194	9205	9449	1133
Receivables Turnover	1795	8801	1970	7289	8328
Days Sales Outstanding	6112	2943	3691	9702	5838
Inventory Turnover	2120	9204	1328	6939	9368
Days Inventory Outstanding	2080	7412	6060	9616	5605
Payables Turnover	8724	3512	2116	4874	4983
Days Payables Outstanding	6320	8499	9182	7440	1468
Liquidity Ratios
Current Ratio	5593	7714	6568	1650	3926
Quick Ratio	3118	9706	9700	6804	3043
Cash Ratio	8463	6365	4301	4387	6263
Coverage Ratios
Cash Flow Coverage Ratio	7178	5760	9005	3452	2850
Debt Ratios
Debt-to-Equity Ratio	5015	6893	4569	1836	2089
Debt Ratio	1203	8379	1287	2740	7108
Net Debt	4675	9089	9027	9188	1754
Interest Coverage Ratio	6189	3034	1164	1971	9273
Debt Service Coverage Ratio	8047	8405	2798	4002	4895
Net Debt/EBITDA	3195	6283	2074	9962	8466
Solvency Ratios
Runway (in months)	1755	4563	3385	2887	6071
Growth Ratios
Revenue Growth Rate (CAGR)	7440	4875	9452	3852	9196
Earnings Growth Rate (CAGR)	5387	4287	9314	4400	6623

To access detailed financial performance and data, Buy Financial Report FY 25 Available

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Compounded Annual Growth Rate of POLYPEPTIDE LABORATORIES PRIVATE LIMITED

Revenue CAGR	Growth
1 Year	34%
3 Year	336
5 Year	707

EBITDA CAGR	Growth
1 Year	20%
3 Year	650
5 Year	471

Disclaimer

There are 5 delayed MSME payments recorded for POLYPEPTIDE LABORATORIES PRIVATE LIMITED during Apr 2025 - Sep 2025.

Here are the details of MSME payment delays for this period:

Supplier Name	Supplier PAN	Amount Due	Due since
Tempcool Shipper	6082	1086	8000
APP	1295	5097	5375
Groverso ns Shipping Services Pvt Limited	8831	3108	5115
Lipi Industrial Services	2275	9785	4077
Pollution Protectio n Systems Mumbai Pvt. Ltd.	3018	7952	5038

To access detailed supplier-wise and period-wise MSME payment delay information, Buy Detailed Report

Board of Directors of POLYPEPTIDE LABORATORIES PRIVATE LIMITED

Here is the list of current board of directors of POLYPEPTIDE LABORATORIES PRIVATE LIMITED:

Name	Designation	Status	Appointment Date	Duration
Ashok Dattatraya Alate	Director	Current	Feb 06, 2001	25 Years 5 Months
Jens Fricke	Director	Current	Mar 29, 2023	3 Years 3 Months
Juan Jose Gonzalez casanova	Director	Current	Jul 19, 2023	3 Years

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

Signatories of POLYPEPTIDE LABORATORIES PRIVATE LIMITED

Here is the list of current signatories of POLYPEPTIDE LABORATORIES PRIVATE LIMITED:

Name	Designation(s)	Status	Appointment Date	Duration
Ashok Dattatraya Alate	Director	Current	Feb 06, 2001	25 Years 5 Months
Navleen kaur Surinder Anand	Company Secretary	Current	Apr 01, 2021	5 Years 3 Months
Jens Fricke	Director	Current	Mar 29, 2023	3 Years 3 Months
Juan Jose Gonzalez casanova	Director	Current	Jul 19, 2023	3 Years

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

Cross Directorships of POLYPEPTIDE LABORATORIES PRIVATE LIMITED

POLYPEPTIDE LABORATORIES PRIVATE LIMITED has directors who also hold positions in 5 other legal entities. All are listed below:

Legal Entity Name	% of Common Directors	Common Director(s)	Open Charge(s)	Active Legal Case(s)
BIBAWO MEDICAL PRIVATE LIMITED CIN: U36999MH2017PTC299326, India, Active	929	975	223	782
ALOKE SPECIALTY MACHINES & COMPONENTS PR IVATE LIMITED CIN: U45200MH1996PTC160684, India, Active	212	555	560	668
JANVILLE LEARNING SYSTEMS PRIVATE LIMITED CIN: U80100MH2005PTC152941, India, Active	689	824	168	521
FOREFRONT MEDTECH PRIVATE LIMITED CIN: U24230MH2005PTC155037, India, Active	991	524	315	969
FERRING LIFE SCIENCES PRIVATE LIMITED CIN: U24239MH2006PTC165489, India, Strike off	829	380	887	863

To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report

POLYPEPTIDE LABORATORIES PRIVATE LIMITED has an employee count of 98 as on Mar 31, 2024.

Employee count trend for POLYPEPTIDE LABORATORIES PRIVATE LIMITED

Date	Employee Count
Mar 24	98
Feb 24	777
Jan 24	155
Dec 23	328
Nov 23	475
Oct 23	909
Sep 23	883

PolyPeptide is the only brand associated with POLYPEPTIDE LABORATORIES PRIVATE LIMITED, and here are its Top 10 competitors ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AmbioPharm 2006, North Augusta (United States), Acquired	Peptide manufacturing and development services, setting a new standard worldwide	$24M	The Carlyle Group, Thecarlylegroup.fr & 1 others	58/100
2nd	Enzene 2015, Pune (India), Series C	Company specializing in development of Biosimilars	$50M	F-Prime Capital, Eight Roads Ventures & 1 others	55/100
3rd	Shaanxi Micot Technology 2007, China, Public	Provider of drug research and development services focused on cardiovascular and metabolic diseases	$72.2M	NLVC, Tasly & 2 others	48/100
4th	PolyPeptide 1952, Baar (Switzerland), Public	CMO manufacturing proprietary,GMP grade and non-GMP-grade peptides	-	-	48/100
5th	Hybio Pharmaceutical 1998, Shenzhen (China), Public	Developer and manufacturer of polypeptide drugs and APis	$15M	Shenzhen Capital Group, SAIF Partners & 1 others	43/100
6th	JPT Peptide 2004, Berlin (Germany), Acquired	Peptide based CRO offering proteomics, biomarker and drug discovery services	-	-	41/100
7th	Custom Peptide Synthesis 2011, Mumbai (India), Unfunded	Manufacturer of peptides and other finished formulations, & APIs	-	-	40/100
8th	Proteos Biotech 2010, Madrid (Spain), Unfunded	Manufacturer of recombinant enzymes and provides CMO services	-	-	38/100
9th	Rameda 1994, Giza (Egypt), Public	Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products	-	Public Investment Fund, Compass Capital	37/100
10th	USV Peptides 2011, Mumbai (India), Unfunded	CDMO offering custom peptide, GMP peptide and cosmetic peptide synthesis services	-	-	34/100

To view the full list of competitors of PolyPeptide, Buy Detailed Report

Media has covered brands linked with POLYPEPTIDE LABORATORIES PRIVATE LIMITED for a total of 15 events in the last 1 year, 5 of them have been about company updates and 2 about partnerships.